Skip to content
Disclosery

EXANE DERIVATIVES: EXP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on EXP, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,258 EXP shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,258 shares
    Change vs previous 13F -491 shares

    0.08% of the 13F portfolio, value $138,276.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,749 shares
    Change vs previous 13F -776 shares

    0.06% of the 13F portfolio, value $224,488.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,525 shares
    Change vs previous 13F -3,207 shares

    0.1% of the 13F portfolio, value $420,296.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 5,732 shares
    Change vs previous 13F -1,205 shares

    0.19% of the 13F portfolio, value $751,782.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 6,937 shares
    Change vs previous 13F +6,352 shares

    0.22% of the 13F portfolio, value $959,226.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 585 shares
    Change vs previous 13F +94 shares

    0.02% of the 13F portfolio, value $78,626.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 491 shares
    Change vs previous 13F +209 shares

    0.02% of the 13F portfolio, value $49,761.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 282 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $24,341.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).